TLR7/NF-kB Leeporter™ Luciferase Reporter-HEK293 Cell Line
Fig-1: Induction of TLR7 activity by R848 in TLR7/NF-kB Leeporter™ - HEK293 cells.
Roll over image to zoom in
Shipping Info:
Order now and get it on Friday November 22, 2024
Same day delivery FREE on San Diego area orders placed by 1.00 PM
Amount : | 1 Vial |
Content : | Each vial contains 2 ~ 3 x 10^6 cells in 1 ml of 90% FBS + 10% DMSO. |
Storage condition : | Immediately upon receipt, store in liquid nitrogen. |
The TLR7/NF-kB Leeporter™ Luciferase Reporter cell line is a stably transfected HEK 293 cell line which expresses full-length human Toll-like receptor 7 (TLR7) and Renilla luciferase reporter gene under the transcriptional control of the NF-kB response element. TLR7 is one of the key innate immune receptors. Functional activity of the cell line has been validated by TLR7 ligand assay, in which upon activation by R848, TLR7 quickly initiates downstream signaling pathway and mediates nuclear translocation of NF-kB (Figure 1).
Application:
- Monitor the TLR7 signaling pathway activity.
- Screen for activators or inhibitors of the TLR7 signaling pathway.
Culture conditions:
Functional validation:
LIMITED USE RESTRICTIONS:
THIS PRODUCT IS SOLELY FOR IN VITRO RESEARCH USE ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE.
By use of this product, user agrees to be bound by the terms of this limited use statement.
This product is solely for Internal Research Purposes and not for Commercial Purposes. Commercial Purposes include, but are not limited to (1) use of the cell line in manufacturing; (2) use of the cell line to provide a service, information or data; (3) use of the cell line for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the cell line whether or not such cell lines are resold for use in research. The buyer cannot sell, give or otherwise transfer this product to a third party.
Commercial License Agreement is available for non-research use if applicable. Please contact Abeomics ([email protected]).
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
1. Affonso de Oliveira JF, Moreno-Gonzalez MA, Ma Y, Deng X, Schuphan J, Steinmetz NF.
Plant Virus Intratumoral Immunotherapy with CPMV and PVX Elicits Durable Antitumor Immunity in a Mouse Model of Diffuse Large B-Cell Lymphoma.
Mol Pharm. 2024 Nov 11. doi: 10.1021/acs.molpharmaceut.4c00507. Epub ahead of print.
PMID: 39526560.
There are currently no product reviews
|